Lactogynal (lactobacillus acidophilus) 14 capsules

Instructions for Lactogynal (lactobacillus acidophilus) 14 capsules

Nosology Lactogynal (ICD codes)

• N76
• Other inflammatory diseases of vagina and vulva
• N89.8
• Other noninflammatory diseases of vagina
• Y40.7
• Systemic antifungal antibiotics
• Y40.9
• Unspecified systemic antibiotics
• Z29.8
• Other specified preventive measures
• Z51.4
• Preparatory procedures for follow-up treatment or examination, not elsewhere classified

Features

Release Form Capsules Lactogynal
Vacation Order Over the counter

Active ingredient
Lyophilized culture of lactobacillus (Lactobacillus casei rhamnosus doderleini)
Scope of application Gynecology

Quantity in packing 14 pcs

Dosage of active ingredient 1×108 KOE
Instructions for use

Active substances Lactogynal
Lactobacteria

Release Form
Capsules

Composition Lactogynal

Active Ingredient: Lyophilized Lactobacillus Culture Lactobacillus casei rhamnosus DoderleiniActive Ingredient Concentration (Units): Lyophilized Lactobacillus Culture 341 mg,

Testimony Lactogynal

•  restoration of normal microflora of vagina after antibacterial therapy of bacterial vaginosis;
• at preparation for carrying out of routine gynecological operations;
• at prenatal preparation for carrying out of routine gynecological operations;
• at prenatal preparation of pregnant women belonging to a group of risk in relation to bacterial vaginosis.

Method of application and dose Lactogynal

To restore normal vaginal microflora after antibacterial therapy of bacterial vaginosis: one capsule in the morning and evening for seven days or 1 capsule daily for fourteen days. In preparation for elective gynecological operations; in prenatal preparation of pregnant women for elective gynecological operations; in prenatal preparation of pregnant women who are at risk of bacterial vaginosis: one capsule in the morning and evening for seven days or one capsule daily for 14 days - as part of complex therapy. The capsule should be placed in the vagina, soaked in a small amount of water to accelerate dissolution of the drug.The dosing regimen should be adjusted depending on the severity of the clinical effect.

Pharmacological effect Lactogynal

eubiotics for intravaginal use. Lactobacillus casei are gram-positive rod-shaped anaerobic nonspore-forming bacteria. Lactobacillus casei is a normal obligate flora of the mouth, intestine, vulva, and vagina in humans. Lactobacillus casei, along with other types of lactobacilli (including L. acidophilus, L. fermentum, L. cellobiosum), are present in the normal flora of the vulva and vagina of women. Live rod colonization of the vagina Lactobacillus casei rhamnosus doderleini creates a vaginal physiologic environment similar to that of the vagina. Lactojinal Lactobacillus casei rhamnosus doderleini strain has antagonistic activity against a wide range of pathogenic and opportunistic bacteria (including Staphylococcus spp., Proteus spp., enteropathogenic Escherichia coli), improves local metabolic processes, and promotes restoration of natural local immunity. When the lactoginal capsule is inserted into the vagina, the gelatin sheath of the capsule dissolves, releasing the lyophilized culture of live lactobacilli. In vitro Lactobacillus casei rhamnosus doderleini has been shown to induce pH reduction within hours of administration, contributing to the restoration of the vaginal natural microflora.